131 related articles for article (PubMed ID: 6162644)
1. Altered androgen metabolism in carcinoma of the prostate.
Ghanadian R; Masters JR; Smith CB
Eur Urol; 1981; 7(3):169-70. PubMed ID: 6162644
[TBL] [Abstract][Full Text] [Related]
2. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
Bard DR; Lasnitzki I
J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
[TBL] [Abstract][Full Text] [Related]
3. Androgen metabolism by human prostatic tumours in organ culture.
Smith CB; Masters JR; Metcalfe SA; Ghanadian R
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):929-34. PubMed ID: 6684049
[TBL] [Abstract][Full Text] [Related]
4. Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
Klein H; Bressel M; Kastendieck H; Voigt KD
Am J Clin Oncol; 1988; 11 Suppl 2():S30-6. PubMed ID: 2853935
[TBL] [Abstract][Full Text] [Related]
5. Androgen binding and metabolism in the human prostate.
Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
[No Abstract] [Full Text] [Related]
6. Evaluation of androgen metabolism studies in human prostate cancer--correlation with zinc levels.
Habib FK
Prev Med; 1980 Sep; 9(5):650-6. PubMed ID: 6159623
[No Abstract] [Full Text] [Related]
7. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
Hudson RW; Wherrett D
J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
[TBL] [Abstract][Full Text] [Related]
8. Androgen concentration in blacks with benign and malignant prostatic disease.
Osegbe DN; Ogunlewe JO
J Urol; 1988 Jul; 140(1):160-4. PubMed ID: 2454327
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
Perel E; Killinger DW
J Steroid Biochem; 1983 Aug; 19(2):1135-9. PubMed ID: 6193342
[TBL] [Abstract][Full Text] [Related]
10. Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
Altwein JE; Orestano F; Hohenfellner R
Invest Urol; 1974 Sep; 12(2):157-61. PubMed ID: 4854628
[No Abstract] [Full Text] [Related]
11. Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
Lasnitzki I
J Steroid Biochem; 1979 Jul; 11(1B):625-30. PubMed ID: 90755
[No Abstract] [Full Text] [Related]
12. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
[TBL] [Abstract][Full Text] [Related]
13. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
14. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
Baranowska B; Zgliczyński S
Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
[TBL] [Abstract][Full Text] [Related]
15. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
[TBL] [Abstract][Full Text] [Related]
16. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
18. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
[No Abstract] [Full Text] [Related]
19. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
20. Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia.
Schweikert HU; Totzauer P; Rohr HP; Bartsch G
J Urol; 1985 Aug; 134(2):403-7. PubMed ID: 2410636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
